PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Chemische Eigenschaften,Einsatz,Produktion Methoden

• S-Sätze Betriebsanweisung:

  S22:Staub nicht einatmen.
  S24/25:Berührung mit den Augen und der Haut vermeiden.

• Verwenden

  Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt has been used in cell culture for pharmaceutical inhibition and activation studies.

• Allgemeine Beschreibung

  Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt inhibits the protein kinase cAMP-activated catalytic subunit-α (PRKACA). The gene encoding it is localized on human chromosome 19p13.1.

• Biochem/physiol Actions

  Mutations in the gene encoding protein kinase cAMP-activated catalytic subunit-α (PRKACA) have been associated with Cushing′s syndrome.

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(2)Suppliers